ATE238793T1 - Verfahren zur förderung von ovulation und geburt bei säugetieren - Google Patents

Verfahren zur förderung von ovulation und geburt bei säugetieren

Info

Publication number
ATE238793T1
ATE238793T1 AT97122131T AT97122131T ATE238793T1 AT E238793 T1 ATE238793 T1 AT E238793T1 AT 97122131 T AT97122131 T AT 97122131T AT 97122131 T AT97122131 T AT 97122131T AT E238793 T1 ATE238793 T1 AT E238793T1
Authority
AT
Austria
Prior art keywords
mammals
receptor antagonist
domperidone
mammal
birth
Prior art date
Application number
AT97122131T
Other languages
English (en)
Inventor
Dee L Cross
Original Assignee
Univ Clemson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Clemson filed Critical Univ Clemson
Application granted granted Critical
Publication of ATE238793T1 publication Critical patent/ATE238793T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97122131T 1996-12-18 1997-12-16 Verfahren zur förderung von ovulation und geburt bei säugetieren ATE238793T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/768,981 US6224895B1 (en) 1996-12-18 1996-12-18 Method for promoting ovulation, parturition, and lactation in mammals

Publications (1)

Publication Number Publication Date
ATE238793T1 true ATE238793T1 (de) 2003-05-15

Family

ID=25084046

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97122131T ATE238793T1 (de) 1996-12-18 1997-12-16 Verfahren zur förderung von ovulation und geburt bei säugetieren

Country Status (7)

Country Link
US (2) US6224895B1 (de)
EP (1) EP0848954B1 (de)
AT (1) ATE238793T1 (de)
AU (1) AU731045B2 (de)
CA (1) CA2224912C (de)
DE (1) DE69721462T2 (de)
NZ (1) NZ329407A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224895B1 (en) * 1996-12-18 2001-05-01 Clemson University Method for promoting ovulation, parturition, and lactation in mammals
WO2002007758A2 (en) 2000-07-21 2002-01-31 Monsanto Technology Llc Method for induced lactation
US6534526B2 (en) 2001-07-16 2003-03-18 Clemson University Laminitis in horses
WO2004045613A2 (en) * 2002-11-20 2004-06-03 Pantarhei Bioscience B.V. Use of domperidone for reducing fertility in mammalian females
WO2004082570A2 (en) * 2003-03-17 2004-09-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dopamine receptor d2 (drd2)
US7736097B2 (en) * 2006-04-14 2010-06-15 M&D Environmental Barriers, Llp Environmental barrier device
US20080181730A1 (en) * 2006-04-14 2008-07-31 Siltshield, Llc Environmental barrier device
CN100402087C (zh) * 2006-05-31 2008-07-16 宁波市三生药业有限公司 冻干混悬性粉针剂及其制备方法
ES2354791B1 (es) * 2009-03-31 2011-12-23 Laboratorios Del Dr. Esteve, S.A. Domperidona a una dosis diaria baja para su uso en el tratamiento o la prevención de una enfermedad asociada a una alteración de la respuesta inmunitaria.
EP2241317A1 (de) * 2009-03-31 2010-10-20 Laboratorios Del. Dr. Esteve, S.A. Domperidon mit einer geringen täglichen Dosis zur Verwendung bei der Behandlung oder Vorbeugung einer Krankheit in Verbindung mit einer Veränderung der Immunantwort
EP2470184B1 (de) * 2009-08-28 2018-08-01 Bellweather Farms Chemische laktationsinduktion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066772A (en) 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
US4005211A (en) 1975-09-10 1977-01-25 Janssen Pharmaceutica N.V. Lactation stimulation employing pimozide
US4755519A (en) 1986-05-22 1988-07-05 University Of Kentucky Research Foundation Methods of treating and preventing tall fescue toxicosis by the administration of thiamin
DE3772764D1 (de) 1987-06-30 1991-10-10 Ile De France Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl)-methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.
US4880632A (en) 1987-09-08 1989-11-14 The United States Of America Prevention of fescue toxicosis
US4847243A (en) 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
IL87982A0 (en) 1988-10-10 1989-03-31 Israel Oceanographic & Limnolo Compositions and methods for manipulating ovulation and spawning in fish
US5372818A (en) 1993-02-01 1994-12-13 Clemson University Method of treating fescue toxicosis with domperidone
US6224895B1 (en) * 1996-12-18 2001-05-01 Clemson University Method for promoting ovulation, parturition, and lactation in mammals

Also Published As

Publication number Publication date
EP0848954B1 (de) 2003-05-02
CA2224912A1 (en) 1998-06-18
DE69721462D1 (de) 2003-06-05
DE69721462T2 (de) 2004-02-19
EP0848954A1 (de) 1998-06-24
CA2224912C (en) 2006-10-10
US6455546B2 (en) 2002-09-24
AU4828497A (en) 1998-06-25
AU731045B2 (en) 2001-03-22
US6224895B1 (en) 2001-05-01
US20010005724A1 (en) 2001-06-28
NZ329407A (en) 1999-05-28

Similar Documents

Publication Publication Date Title
DE69721462D1 (de) Verfahren zur Förderung von Ovulation und Geburt bei Säugetieren
DE3587266D1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
BR9710689A (pt) Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
IL92269A0 (en) Pharmaceutical composition for treatment of autoimmune diseases
AU7827587A (en) Methods and agents for removing advanced glycosylation endproducts
Whiteside A controlled study of benzydamine oral rinse (‘Difflam’) in general practice
AU2002334001B2 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
Maeda-Hagiwara et al. Influence of clonidine and a new related imidazoline derivative (tizanidine) on rat gastric mucosa
Labrie et al. Growth hormone inhibition of hydrocortisone induction of tyrosine transaminase and tryptophan pyrrolase and its reversal by amino acids
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
WO1996020950A3 (en) Compositions and methods for treating rheumatoid arthritis
Ishii et al. Stress response to surgical procedures in the submandibular region and its influence on salivary secretion in mice
EP0279867A3 (de) Verwendung von Vitamin-E und Vitamin-E-Kombination mit nichtsteroidalen Antirheumatika und Schmerzmittel zur Behandlung von rheumatischen Erkrankungen
ATE167628T1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion
US3879548A (en) Method of treating milk fever in dairy cattle with 1-alpha-hydroxycholecalciferol
Toscani et al. Nimesulide in the treatment of advanced cancer pain: double-blind comparison with naproxen
ATE220330T1 (de) Deltorphin zur behandlung von ischemie
Migasena et al. Mebendazole, tetrachlorethylene and pyrantel pamoate in the treatment of hookworm infection
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
ATE197764T1 (de) Zusammensetzung zur behandlung des insulinmangels bei säugetieren, die amylin und insulin enthält.
WO2002043566A3 (en) Devices and methods for treating low blood sugar levels
ATE234619T1 (de) Verwendung von spiramyeine in von h.pylori verursachten magen und darm beschwerden
McCloghry et al. The effects of exogenous melatonin and prolactin on wool follicle development in ovine foetal skin grafts

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties